Immunotherapy in Lung Cancer

e-ESO Podcasts - A podcast by ESO - European School of Oncology

Categories:

Expert: Elisa Gobbini, Gustave Roussy Institute, Villejuif, FR Questions: 1-What is the role of immunotherapy in PD-L1 negative mNSCLC? 2-Could you describe the rational for cases with negative PDL1 responding to immunotherapy? 3-What about liquid PDL-1 assay and how to be implemented in clinical practice? 4-How long the duration required for re-exposition to previously received immunotherapy? 5-Patients with history of auto-immune diseases, there are any criteria to select the patient who will be candidate to receive immunotherapy or not?